Mann‐Jen Hour

1.3k total citations
38 papers, 1.1k citations indexed

About

Mann‐Jen Hour is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Mann‐Jen Hour has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Mann‐Jen Hour's work include Quinazolinone synthesis and applications (11 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cancer therapeutics and mechanisms (3 papers). Mann‐Jen Hour is often cited by papers focused on Quinazolinone synthesis and applications (11 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Cancer therapeutics and mechanisms (3 papers). Mann‐Jen Hour collaborates with scholars based in Taiwan, United States and Russia. Mann‐Jen Hour's co-authors include Sheng‐Chu Kuo, Li‐Jiau Huang, Kuo‐Hsiung Lee, Yi Xia, Yuka Nakanishi, Kenneth F. Bastow, Ernest Hamel, Jai‐Sing Yang, Jin‐Cherng Lien and Wen Fu and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mann‐Jen Hour

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mann‐Jen Hour Taiwan 18 531 436 93 79 78 38 1.1k
Haiwei Xu China 20 596 1.1× 318 0.7× 83 0.9× 55 0.7× 74 0.9× 64 1.2k
Heying Pei China 18 289 0.5× 427 1.0× 150 1.6× 111 1.4× 94 1.2× 56 935
Thikryat Neamatallah Saudi Arabia 18 200 0.4× 301 0.7× 86 0.9× 64 0.8× 80 1.0× 41 865
Tamer M. Abdelghany Egypt 24 333 0.6× 556 1.3× 126 1.4× 55 0.7× 44 0.6× 54 1.3k
Rohan J. Meshram India 16 392 0.7× 330 0.8× 96 1.0× 23 0.3× 50 0.6× 48 877
Emika Ohkoshi Japan 23 369 0.7× 472 1.1× 108 1.2× 140 1.8× 90 1.2× 49 1.1k
Yong Yin China 22 480 0.9× 699 1.6× 97 1.0× 34 0.4× 116 1.5× 61 1.4k
Yuba Raj Pokharel India 18 305 0.6× 531 1.2× 217 2.3× 116 1.5× 78 1.0× 59 1.1k
Ahmed H.E. Hassan Egypt 23 444 0.8× 449 1.0× 185 2.0× 47 0.6× 43 0.6× 89 1.2k

Countries citing papers authored by Mann‐Jen Hour

Since Specialization
Citations

This map shows the geographic impact of Mann‐Jen Hour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mann‐Jen Hour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mann‐Jen Hour more than expected).

Fields of papers citing papers by Mann‐Jen Hour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mann‐Jen Hour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mann‐Jen Hour. The network helps show where Mann‐Jen Hour may publish in the future.

Co-authorship network of co-authors of Mann‐Jen Hour

This figure shows the co-authorship network connecting the top 25 collaborators of Mann‐Jen Hour. A scholar is included among the top collaborators of Mann‐Jen Hour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mann‐Jen Hour. Mann‐Jen Hour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hour, Mann‐Jen, Fuu Jen Tsai, I‐Lu Lai, et al.. (2023). Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells. Biomedicine. 13(4). 20–31. 6 indexed citations
3.
Hour, Mann‐Jen, et al.. (2022). Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity. International Journal of Molecular Sciences. 23(18). 10309–10309. 10 indexed citations
4.
Балтина, Л. А., Hsueh‐Chou Lai, Su-Hua Huang, et al.. (2021). Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro. Bioorganic & Medicinal Chemistry. 41. 116204–116204. 34 indexed citations
5.
6.
Yang, Jai‐Sing, Fuu‐Jen Tsai, Chengwei Li, et al.. (2021). Establishment of a Novel Temozolomide Resistant Subline of Glioblastoma Multiforme Cells and Comparative Transcriptome Analysis With Parental Cells. Anticancer Research. 41(5). 2333–2347. 4 indexed citations
7.
Балтина, Л. А., Mann‐Jen Hour, Su-Hua Huang, et al.. (2020). Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus. Virus Research. 294. 198290–198290. 19 indexed citations
8.
You, Bang‐Jau, et al.. (2019). Fenofibrate induces human hepatoma Hep3B cells apoptosis and necroptosis through inhibition of thioesterase domain of fatty acid synthase. Scientific Reports. 9(1). 3306–3306. 27 indexed citations
9.
Hour, Mann‐Jen, et al.. (2017). Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus. Viruses. 9(4). 76–76. 15 indexed citations
10.
Lin, Tzu‐Hung, Yung‐Cheng Chiu, Chih‐Hsin Tang, et al.. (2014). 5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts. PLoS ONE. 9(9). e107890–e107890. 55 indexed citations
11.
Liu, Wei-Ting, Sheng‐Chu Kuo, Kuo‐Hsiung Lee, et al.. (2014). MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complex. Neuropharmacology. 86. 219–227. 22 indexed citations
12.
Kang, Kai‐Hsiang, Thai‐Yen Ling, Horng‐Huei Liou, et al.. (2013). Enhancement role of host 12/15-lipoxygenase in melanoma progression. European Journal of Cancer. 49(12). 2747–2759. 19 indexed citations
13.
Chen, Hui‐Jye, Yilin Jiang, Chung-Ming Lin, et al.. (2013). Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells. International Journal of Oncology. 43(1). 141–150. 27 indexed citations
14.
Kang, Kai‐Hsiang, et al.. (2013). Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology. 73. 380–387. 51 indexed citations
15.
Leung, Yuk‐Man, et al.. (2010). Arylnaphthalene lignans from Taiwania cryptomerioides as novel blockers of voltage-gated K+ channels. Phytomedicine. 18(1). 46–51. 8 indexed citations
16.
Lien, Jin‐Cherng, Chi‐Rei Wu, Mann‐Jen Hour, et al.. (2008). Synthesis of 2,3‐Disubstituted 1,4‐Naphthoquinones as Antiplatelet Agents. Archiv der Pharmazie. 341(10). 639–644. 3 indexed citations
17.
Chao, Chia‐Chia, et al.. (2008). HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells. Neuropharmacology. 54(7). 1128–1135. 14 indexed citations
18.
Hour, Mann‐Jen, et al.. (2007). Chaperones are the target in aloe-emodin-induced human lung nonsmall carcinoma H460 cell apoptosis. European Journal of Pharmacology. 573(1-3). 1–10. 24 indexed citations
19.
Hour, Mann‐Jen, et al.. (2001). Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 11(3). 279–282. 89 indexed citations
20.
Hour, Mann‐Jen, et al.. (2000). Synthesis and Antiplatelet Activity of Alkoxy Derivatives of 2- Phenylquinazolines. Zhōnghuá yàoxué zázhì. 52. 167–177. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026